A detailed history of Nomura Holdings Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Nomura Holdings Inc holds 210,624 shares of ANIP stock, worth $11.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
210,624
Holding current value
$11.9 Million
% of portfolio
0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$54.33 - $65.72 $11.4 Million - $13.8 Million
210,624 New
210,624 $12.6 Million
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $1.95 Million - $2.57 Million
30,062 Added 8.01%
405,511 $29.4 Million
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $6.47 Million - $7.85 Million
95,462 Added 34.1%
375,449 $31.1 Million
Q1 2019

May 14, 2019

BUY
$45.83 - $70.54 $9.6 Million - $14.8 Million
209,441 Added 296.89%
279,987 $19.5 Million
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $8.5 Million - $11.7 Million
-206,463 Reduced 74.53%
70,546 $3.17 Million
Q3 2018

Nov 14, 2018

SELL
$52.95 - $71.34 $1.75 Million - $2.36 Million
-33,106 Reduced 10.68%
277,009 $15.6 Million
Q2 2018

Aug 14, 2018

BUY
$56.38 - $68.08 $1.59 Million - $1.92 Million
28,134 Added 9.98%
310,115 $19.2 Million
Q1 2018

May 14, 2018

SELL
$56.98 - $72.41 $16.2 Million - $20.6 Million
-284,261 Reduced 50.2%
281,981 $16.4 Million
Q1 2018

May 14, 2018

BUY
$56.98 - $72.41 $16.1 Million - $20.4 Million
281,981 Added 99.2%
566,242 $34.7 Million
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $2.33 Million - $3.26 Million
43,733 Added 18.18%
284,261 $18.3 Million
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $10.5 Million - $12.6 Million
240,528
240,528 $12.6 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.